You have 9 free searches left this month | for more free features.

MET dysregulation

Showing 1 - 25 of 2,073

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Solid Tumors Trial in Goyang-si, Seoul (ABN401)

Not yet recruiting
  • Advanced Solid Tumors
  • Goyang-si, Gyeonggi-Do, Korea, Republic of
  • +2 more
Sep 13, 2022

Advanced Hepatocellular Carcinoma With c-MET Dysregulation Trial in Worldwide (INC280)

Active, not recruiting
  • Advanced Hepatocellular Carcinoma With c-MET Dysregulation
  • Nanjing, Jiangsu, China
  • +7 more
Jan 12, 2023

Advanced Solid Tumors Trial in Australia, Korea, Republic of (ABN401- Escalation Phase, ABN401- Expansion Phase)

Recruiting
  • Advanced Solid Tumors
  • ABN401- Escalation Phase
  • ABN401- Expansion Phase
  • Kogarah, New South Wales, Australia
  • +6 more
May 2, 2022

NSCLC Trial in Guangzhou (PLB1001)

Recruiting
  • Non-small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Guangdong General Hospital
Feb 5, 2020

Tabrecta® (Capmatinib) in South Korea

Not yet recruiting
  • Non-Small-Cell Lung Carcinoma
  • Capmatinib
  • (no location specified)
Jan 19, 2023

NSCLC Trial in Worldwide (INC280 (capmatinib))

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • INC280 (capmatinib)
  • Long Beach, California
  • +95 more
Dec 29, 2022

Emotional Regulation, Peace of Mind, Older Adults Trial in Alexandria (constructive emotional management interventions)

Completed
  • Emotional Regulation
  • +2 more
  • constructive emotional management interventions
  • Alexandria, Egypt
  • +1 more
Jun 16, 2023

Solid Tumors Trial in Worldwide (INC280)

Completed
  • Solid Tumors
  • Fayetteville, Arkansas
  • +46 more
Dec 16, 2020

Autism Spectrum Disorder Trial in Ankara (Online-delivered Group-based Parent Mediated Intervention for Young Children with ASD)

Completed
  • Autism Spectrum Disorder
  • Online-delivered Group-based Parent Mediated Intervention for Young Children with ASD
  • Ankara, Turkey
    Hergüner Therapy Private Clinic
Jul 17, 2023

NSCLC (NSCLC) Trial in China (Capmatinib)

Recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • Xiamen, Fujian, China
  • +18 more
Jan 27, 2023

Asthma, Obesity, Metabolic Syndrome Trial in Aurora (Bronchoscopy and Nasal Epithelium Brush Sampling)

Recruiting
  • Asthma
  • +2 more
  • Bronchoscopy and Nasal Epithelium Brush Sampling
  • Aurora, Colorado
    University of Colorado
Sep 17, 2021

Empathy Anomalies in Emotionally Unstable Personality Disorder

Not yet recruiting
  • Emotionally Unstable Personality Disorder, Borderline Type
    • (no location specified)
    May 19, 2022

    Tumors Trial (ABN401)

    Not yet recruiting
    • Neoplasms
    • (no location specified)
    May 21, 2023

    Complex Post-Traumatic Stress Disorder Trial in Denmark (Psychotherapy)

    Recruiting
    • Complex Post-Traumatic Stress Disorder
    • Psychotherapy
    • Aalborg, Denmark
    • +4 more
    Feb 17, 2022

    Newer Therapeutic Targets in Head and Neck Cancers

    Recruiting
    • Head Neck Cancer
    • Oral Cancer
    • Next generation Sequencing
    • Varanasi, UP, India
      Banaras Hindu University
    May 19, 2022

    Irritable Mood, ADHD Trial in Taipei (Methylphenidate, aripiprazole, and combination)

    Completed
    • Irritable Mood
    • ADHD
    • Methylphenidate, aripiprazole, and combination
    • Taipei, Taiwan
      Tri-Service General Hospital, National Defense Medical Center
    Aug 4, 2023

    Non Small Cell Lung Cancer Trial in Worldwide (Capmatinib, Nazartinib)

    Terminated
    • Non Small Cell Lung Cancer
    • Boston, Massachusetts
    • +18 more
    Jul 20, 2022

    Autism Spectrum Disorder, Emotion Regulation Trial in Cincinnati (Regulating Together-Canine, Regulating Together-Standard)

    Recruiting
    • Autism Spectrum Disorder
    • Emotion Regulation
    • Regulating Together-Canine
    • Regulating Together-Standard
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Apr 6, 2023

    NSCLC Trial (HS-10241+ Almonertinib, Pemetrexed + Cisplatin /Carboplatin)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • HS-10241+ Almonertinib
    • Pemetrexed + Cisplatin /Carboplatin
    • (no location specified)
    Oct 29, 2023

    Older Adults, Healthy Aging, Aging Trial (danceSing Care)

    Not yet recruiting
    • Older Adults
    • +5 more
    • danceSing Care
    • (no location specified)
    Oct 27, 2022

    NSCLC Trial in Worldwide (INC280, Gefitinib)

    Completed
    • Non-small Cell Lung Cancer
    • Woolloongabba, Queensland, Australia
    • +30 more
    Mar 12, 2021

    NSCLC Metastatic Trial in Seoul (Lazertinib, Tepotinib)

    Not yet recruiting
    • Non-Small Cell Lung Cancer Metastatic
    • Seoul, Gangnam-gu, Korea, Republic of
      Samsung Medical Center
    Oct 27, 2023

    Lung Non-Small Cell Carcinoma Trial (Amivantamab, Biospecimen Collection, Computed Tomography)

    Not yet recruiting
    • Lung Non-Small Cell Carcinoma
    • Amivantamab
    • +3 more
    • (no location specified)
    Oct 30, 2023

    Inpatient Evaluation of Adults With Schizophrenia

    Recruiting
    • Schizophrenia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Cardiac Surgery, Acute Kidney Injury Trial in Amiens (blood sample)

    Recruiting
    • Cardiac Surgery
    • Acute Kidney Injury
    • blood sample
    • Amiens, France
      CHU Amiens Picardie
    Apr 5, 2023